RESULTS: DM tolerated 3 hours of constant CO2 anesthesia in combination with X-ray radiation exposure throughout the uCT acquisition, during which the optimal scanning protocol achieved DM survival and minimal image-noise. With this method, successful 3D reconstruction and visualization of DM adults were reproduced at 5.72 um isotropic voxel spacing, with stones clearly present (Fig.1) . Analysis of the impact of BS168 on stone formation is ongoing.
INTRODUCTION AND OBJECTIVES: Absorptive hypercalciuria, or excessive gut absorption of dietary calcium, is the most commonly identified metabolic cause of calcium-based renal stones. Since intestinal commensal bacteria are known to play an integral role in nutrient metabolism, we hypothesized that gut microbiota may affect calcium absorption and tested this using an antibiotic rodent model. METHODS: Young, pathogen-free Sprague-Dawley rats were evenly distributed into untreated controls (UTX; n[12), chloramphenicol-treated (CTX; n[12) and neomycin-treated (NEO; n[12) groups. Urine and feces were collected in metabolic cages before (baseline) and after (1 week, 4 weeks) a 7 day course of 0.07% oral antibiotic treatment in sterile water. Rats received identical amounts of food quantity during collection periods and ad-libitum amounts during the remainder of the protocol. Serum calcium, phosphate, and albumin were measured at 4 weeks on an automated chemistry analyzer. Rat intact PTH, circulating bone turnover markers (BTM), and serum 25(OH)D were measured using commercially available kits. 24-hour urine and fecal calcium samples were analyzed at Litholink Corporation. Intestinal microbiota were chacterized by 16S rRNA Illumina paired-end sequencing, and QIIME and metaGenomeSeq software were used to analyze microbial community differences.
RESULTS: At one week, both male and female CTX animals showed a reversible, 3-fold increase in urinary calcium excretion coupled with a 25% increase in intestinal calcium absorption. These changes resulted in two-fold increase in calcium oxalate and phosphate urinary supersaturation. No differences were observed in serum labs, BTM, PTH, or vitamin D among the three groups. CTX microbial communities were markedly different from UTX and NEO groups by heat-map and discriminant plotting (Figure a/b) .
CONCLUSIONS: In our model, one week of chloramphenicol caused increased intestinal gut calcium absorption and resultant urinary calcium excretion without changes in circulating measures of bone and mineral homeostasis. Gut microbiome was markedly different between the three groups. Should these findings be validated in future studies, functional study of the gut microbial communities responsible for these changes may allow us to target and treat the gut microbiota responsible for absorptive hypercalciuria.
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MP03-09 THE EFFECT OF AN ESCHERICHIA COLI BACTERIAL URINARY INFECTION ISOLATE AND CIPROFLOXACIN ON CALCIUM UROLITHIASIS IN A DROSOPHILA MELANOGASTER MODEL
INTRODUCTION AND OBJECTIVES: Exposure to both urinary bacteria and antibiotics may impact the formation of calcium-based stone disease. Prior epidemiological studies have shown a strong association between the development of stone disease and a history of culture-proven urinary tract infections treated with antibiotics. We aimed to further evaluate the potential effect of a non-urease producing bacteria isolate from a urinary tract infection, and treatment with the antibiotic ciprofloxacin, on the formation of calcium oxalate stones utilizing a Drosophila melanogaster (DM) fly model. METHODS: DM flies were treated with a combination of a nonurease producing strain of Escherichia coli UTI89 and 0.1% sodium oxalate food for the duration of the 14-day assay (n[30 per group). Treatment with ciprofloxacin occurred on day 5-7 of the assay at a sub-minimum inhibitory concentration of 0.2 mg/mL. DM control groups without the addition of UTI89 or ciprofloxacin were included for comparison. Inoculation with UTI89 was confirmed by culturing pulverized flies on lysogeny broth agar plates on days 1-5. Stone burden was assessed with a survival curve analysis and measured pixel intensity of dissected Malpighian tubules under birefringent microscopy.
RESULTS: UTI89 was cultured at a minimum concentration of 3x10 3 colony forming units/fly for up to three days post exposure in treated flies. There was a trend towards decreased survival in oxalate food treated flies for days 15-35; however, UTI89 treatment did not affect fly survival. Preliminary results suggest that at day 7 exposure to UTI89 increased calcium oxalate crystal production in Malpighian tubules (p[0.001), and treatment with ciprofloxacin attenuated this effect (p[0.012, Figure 1 ). Similar trends were observed at day 14; however, these results did not reach statistical significance (Figure 1) . CONCLUSIONS: Our findings further suggest that exposure to both a non-urease producing E. coli and ciprofloxacin may impact calcium oxalate stone formation in a DM urolithiasis model. Further
